Safety of house dust mite allergy treatment in routine care
Part of Immune system & allergy clinical trials.
This study observes how well patients tolerate a specific updosing plan for a house dust mite allergy treatment (Novo-Helisen Depot). It includes children, teens, and adults who are already getting the treatment as part of normal care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an allergy to house dust mites (like allergic rhinitis, eye allergies, or dust-mite-triggered asthma).
- You are at least 5 years old.
- You are starting or continuing treatment with Novo-Helisen Depot using the 'One Strength' updosing plan.
- Your doctor already decided to give you this treatment before you joined the study.
- For children under 18, a parent or legal guardian must also agree to the study.
- You do not have any medical reason that would make this treatment unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This study tests whether heating tissue in the nose (radiofrequency ablation) followed by allergy treatment under the skin (immunotherapy) can reduce long-lasting nasal congestion from dust mite allergy. It may help patients whose symptoms are severe and who have not been able to get enough relief with recent allergy medicines.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
Hear when a new Allergic Rhinitis Due to House Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.